HR Execs on the Move

Sanovia

www.sanovia.com

 
Sanovia s corporate vision is to deliver state-of-the-art products and services which allow its customers to take advantage of advanced technology to improve communications, improve resource utilization through automated workflow processes, advance the quality and appropriateness of care through the integrated use of automated best-practice pharmaceutical clinical guidelines, and control costs.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.sanovia.com
  • 300 Stevens Dr Ste 330
    Philadelphia, PA USA 19113
  • Phone: 610.521.2211

Executives

Name Title Contact Details

Similar Companies

NovaDel Pharma

NovaDel Pharma is a Flemington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phlow

Securing our nation’s pharmaceuticals through U.S. Manufacturing.

Abbott

Abbott is a global healthcare company that conducts innovative research and manufactures products for human health through every life stage. They bring new products and technologies to the world in nutrition, diagnostics, medical devices and branded ge...

Total Care Rx

Total Care RX serves as an extension of the patient’s medical team to monitor medication compliance, provide education and offer other value-added services not offered by retail pharmacies.

Oncopeptides

Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is focusing on the development of the lead product candidate melflufen, a first-in-class anti-cancer peptide-drug conjugate that rapidly delivers an alkylating payload into tumor cells. Melflufen is in development as a new treatment for the hematological cancer multiple myeloma and is currently being evaluated in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study. Oncopeptides` headquarters is in Stockholm, Sweden with U.S. headquarters in Boston, Mass. The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO.